Company
Haya Therapeutics
Search by sector of activity
Santé, sciences de la vie
Search by faculty
Faculté des hautes études commerciales
Daniel Blessing
Haya Therapeutics
Daniel is a biotechnology scientist with 10 years' experience in pharmaceutical biotechnology, particularly in the various translational aspects of drug development and production.
As a post-doctoral fellow at the CHUV, Daniel worked on methods for the delivery and modulation of therapeutic genes using various modalities, including antisense oligonucleotides.
During his PhD at the University of Lausanne and the Ecole Polytechnique Fédérale de Lausanne (EPFL), his work focused on developing new strategies for GMP-compliant manufacturing processes to support various gene therapy applications and clinical trials.